Outcomes	O

The	O
primary	O
outcome	O
was	O
clinical	B-PrimaryOutcome
status	I-PrimaryOutcome
,	O
measured	O
at	B-TimeFrame
15	I-TimeFrame
days	I-TimeFrame
using	B-OutcomeDefinition
a	I-OutcomeDefinition
six	I-OutcomeDefinition
-	I-OutcomeDefinition
level	I-OutcomeDefinition
ordinal	I-OutcomeDefinition
scale	I-OutcomeDefinition
as	I-OutcomeDefinition
follows	I-OutcomeDefinition
:	I-OutcomeDefinition
(	I-OutcomeDefinition
1	I-OutcomeDefinition
)	I-OutcomeDefinition
not	I-OutcomeDefinition
admitted	I-OutcomeDefinition
to	I-OutcomeDefinition
hospital	I-OutcomeDefinition
;	I-OutcomeDefinition
(	I-OutcomeDefinition
2	I-OutcomeDefinition
)	I-OutcomeDefinition
admitted	I-OutcomeDefinition
to	I-OutcomeDefinition
hospital	I-OutcomeDefinition
and	I-OutcomeDefinition
not	I-OutcomeDefinition
using	I-OutcomeDefinition
supplemental	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
;	I-OutcomeDefinition
(	I-OutcomeDefinition
3	I-OutcomeDefinition
)	I-OutcomeDefinition
admitted	I-OutcomeDefinition
to	I-OutcomeDefinition
hospital	I-OutcomeDefinition
and	I-OutcomeDefinition
using	I-OutcomeDefinition
supplemental	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
;	I-OutcomeDefinition
(	I-OutcomeDefinition
4	I-OutcomeDefinition
)	I-OutcomeDefinition
admitted	I-OutcomeDefinition
to	I-OutcomeDefinition
hospital	I-OutcomeDefinition
and	I-OutcomeDefinition
using	I-OutcomeDefinition
non	I-OutcomeDefinition
-	I-OutcomeDefinition
invasive	I-OutcomeDefinition
positive	I-OutcomeDefinition
-	I-OutcomeDefinition
pressure	I-OutcomeDefinition
ventilation	I-OutcomeDefinition
or	I-OutcomeDefinition
high	I-OutcomeDefinition
-	I-OutcomeDefinition
flow	I-OutcomeDefinition
nasal	I-OutcomeDefinition
cannula	I-OutcomeDefinition
;	I-OutcomeDefinition
(	I-OutcomeDefinition
5	I-OutcomeDefinition
)	I-OutcomeDefinition
admitted	I-OutcomeDefinition
to	I-OutcomeDefinition
hospital	I-OutcomeDefinition
and	I-OutcomeDefinition
on	I-OutcomeDefinition
mechanical	I-OutcomeDefinition
ventilation	I-OutcomeDefinition
or	I-OutcomeDefinition
extracorporeal	I-OutcomeDefinition
membrane	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
support	I-OutcomeDefinition
;	I-OutcomeDefinition
or	I-OutcomeDefinition
(	I-OutcomeDefinition
6	I-OutcomeDefinition
)	I-OutcomeDefinition
death	I-OutcomeDefinition
.	O

The	O
key	O
secondary	O
outcome	O
was	O
mortality	B-SecondaryOutcome
at	B-TimeFrame
29	I-TimeFrame
days	I-TimeFrame
after	I-TimeFrame
randomisation	I-TimeFrame
.	O

Other	O
secondary	O
outcomes	O
were	O
clinical	B-SecondaryOutcome
status	I-SecondaryOutcome
assessed	B-OutcomeDefinition
by	I-OutcomeDefinition
the	I-OutcomeDefinition
six	I-OutcomeDefinition
-	I-OutcomeDefinition
point	I-OutcomeDefinition
ordinal	I-OutcomeDefinition
scale	I-OutcomeDefinition
at	B-TimeFrame
7	I-TimeFrame
days	I-TimeFrame
and	I-TimeFrame
29	I-TimeFrame
days	I-TimeFrame
;	O
length	B-SecondaryOutcome
of	I-SecondaryOutcome
hospital	I-SecondaryOutcome
stay	I-SecondaryOutcome
among	I-SecondaryOutcome
survivors	I-SecondaryOutcome
;	O
incidence	B-SecondaryOutcome
of	I-SecondaryOutcome
secondary	I-SecondaryOutcome
infection	I-SecondaryOutcome
(	O
ie	O
,	O
new	B-OutcomeDefinition
infections	I-OutcomeDefinition
arising	I-OutcomeDefinition
after	I-OutcomeDefinition
randomisation	I-OutcomeDefinition
,	I-OutcomeDefinition
whether	I-OutcomeDefinition
nosocomial	I-OutcomeDefinition
or	I-OutcomeDefinition
not	I-OutcomeDefinition
)	O
;	O
and	O
number	B-SecondaryOutcome
of	I-SecondaryOutcome
ventilator	I-SecondaryOutcome
-	I-SecondaryOutcome
free	I-SecondaryOutcome
days	I-SecondaryOutcome
by	B-TimeFrame
day	I-TimeFrame
29	I-TimeFrame
.	I-TimeFrame

Safety	O
outcomes	O
were	O
prolongation	O
of	O
the	O
QTc	O
interval	O
(	O
defined	O
as	O
QTc	O
≥	O
470	O
ms	O
for	O
women	O
or	O
≥	O
450	O
ms	O
for	O
men	O
,	O
in	O
patients	O
whose	O
baseline	O
QTc	O
was	O
below	O
those	O
thresholds	O
,	O
or	O
QTc	O
≥	O
480	O
ms	O
if	O
baseline	O
QTc	O
was	O
above	O
those	O
thresholds	O
)	O
;	O
gastrointestinal	O
intolerance	O
(	O
meaning	O
diarrhoea	O
,	O
nausea	O
,	O
abdominal	O
pain	O
,	O
or	O
vomiting	O
)	O
;	O
laboratory	O
changes	O
in	O
blood	O
counts	O
and	O
bilirubin	O
levels	O
;	O
acute	O
kidney	O
failure	O
(	O
as	O
reported	O
by	O
site	O
investigators	O
)	O
;	O
and	O
overall	O
serious	O
adverse	O
events	O
.	O

